958669-59-5 Usage
Uses
Used in Medicinal Chemistry:
[1,2,4]TRIAZOLO[1,5-A]PYRAZINE, 5,6,7,8-TETRAHYDRO-2-PHENYLis used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a versatile building block in the development of new drugs with potential therapeutic applications.
Used in Pharmaceutical Research:
[1,2,4]TRIAZOLO[1,5-A]PYRAZINE, 5,6,7,8-TETRAHYDRO-2-PHENYLis used as a research tool in the discovery and optimization of new drug candidates. Its potential biological activities make it a valuable compound for studying its interactions with biological targets and evaluating its efficacy in treating various diseases.
Further study and research may be needed to fully understand the properties and potential uses of this chemical compound, as its applications in different industries can be diverse and dependent on the specific requirements of each field.
Check Digit Verification of cas no
The CAS Registry Mumber 958669-59-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,8,6,6 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 958669-59:
(8*9)+(7*5)+(6*8)+(5*6)+(4*6)+(3*9)+(2*5)+(1*9)=255
255 % 10 = 5
So 958669-59-5 is a valid CAS Registry Number.
958669-59-5Relevant articles and documents
PHENYL mTORC INHIBITORS AND USES THEREOF
-
Paragraph 00710, (2018/05/27)
The present invention provides compounds, compositions thereof, and methods of using the same.
Design, synthesis, and biological evaluation of triazolopiperazine-based β-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitors
Kowalchick, Jennifer E.,Leiting, Barbara,Pryor, KellyAnn D.,Marsilio, Frank,Wu, Joseph K.,He, Huaibing,Lyons, Kathryn A.,Eiermann, George J.,Petrov, Aleksandr,Scapin, Giovanna,Patel, Reshma A.,Thornberry, Nancy A.,Weber, Ann E.,Kim, Dooseop
, p. 5934 - 5939 (2008/09/20)
Various β-amino amides containing triazolopiperazine heterocycles have been prepared and evaluated as potent, selective, orally active dipeptidyl peptidase IV (DPP-4) inhibitors. These compounds display excellent oral bioavailability and good overall phar
